Weight Loss in Bellevue, WA
Obesity in adults is defined as a body mass index (BMI) of 30 or more, while severe obesity is a BMI of 40 or more. Obesity is a chronic disease and global health challenge. Obesity can lead to insulin resistance, hypertension, and dyslipidemia, is associated with complications such as type 2 diabetes, cardiovascular disease, and nonalcoholic fatty liver disease, and reduces life expectancy. More recently, obesity has been linked to increased numbers of hospitalizations, the need for mechanical ventilation, and death in persons with coronavirus disease 2019 (Covid-19).
Additionally, obesity is also associated with many chronic pain conditions, including low back pain and fibromyalgia, which can greatly reduce people’s quality of life.
Although lifestyle intervention (diet and exercise) represents the cornerstone of weight management, sustaining weight loss over the long term is challenging. Sometimes pharmacological intervention is warranted. In fact, clinical guidelines suggest adjunctive pharmacotherapy, particularly for adults with a BMI of 30 or greater, or 27 or greater in persons with coexisting conditions.
Dr. O’Connell and Serenity Rejuvenation Center have been offering weight loss solutions to clients since 2010 with great success. We are excited to inform that there are new medications that have gained a lot of popularity which include the brand names Ozempic and Wegovy, and the active chemical in both is called Semaglutide.
Semaglutide is an FDA-approved, once-weekly injectable medication used to achieve weight loss. Semaglutide is also highly effective in treating prediabetes, type 2 diabetes, obesity, and chronic metabolic disease; and in fact lowering the risk of heart attack, stroke, and death in these populations..
This non-surgical weight loss option can restore vitality and increase your quality of life.
Are you ready to learn more about weight loss with semaglutide? Book an appointment with Dr. O’Connell at Serenity Rejuvenation Center, today!
Semaglutide is a glucagon-like peptide-1 receptor agonist. It imitates the action of the incretin GL-1 by increasing insulin production. Semaglutide functions in the areas of the brain that control appetite and food intake. In addition to using Semaglutide, a fitness program and reduced caloric intake will assist in weight loss goals and long-term weight loss management.
- Soreness or sensitivity at the injection site
- Flu-like symptoms
- Increased heart rate
Semaglutide is a once-weekly injectable weight loss treatment.
- Have an individual or family history of thyroid cancer.
- Have a history of pancreatitis.
- Are pregnant or may become pregnant.
- Are currently breastfeeding.
- Are underweight or have been diagnosed with body dysmorphia.